CRL (Charles River Laboratories International) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRL Charles River Laboratories International Inc CRL
70 GF Score
Price $219.40
GF Value $194.04
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International FFO?

FFO (Funds from operations) only applies to REITs.

CRL
70GF Score
Charles River Laboratories International Inc CRL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Charles River Laboratories International (CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of $219.40 is trading 13.1% above its estimated GF Value™ of $194.04. GuruFocus considers Charles River Laboratories International to be Modestly Overvalued.

Key valuation signals for CRL:

  • FFO:
  • GF Value™: $194.04 vs. price of $219.40 (13.1% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges RV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score

Get the complete analysis for CRL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$219.40
Price
$194.04
GF Value